Weld Capital Management’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-5,963
Closed -$781K 330
2021
Q1
$781K Buy
+5,963
New +$864K 0.33% 109
2019
Q2
Sell
-23,368
Closed -$476K 871
2019
Q1
$476K Buy
+23,368
New +$434K 0.09% 403

Other funds holding MRNA

Weld Capital Management's MRNA Position: Q2 2021 in Review

Weld Capital Management sold out of Moderna (MRNA) in Q2 2021, closing a stake of 5,963 shares — an estimated $781K sold.

Weld Capital Management first reported a position in MRNA in Q1 2019 and held it in 2 quarters. The position peaked at $781K in Q1 2021. 904 funds tracked by Wall St. Rank hold MRNA as of Q2 2021.

  • Weld Capital Management reported no remaining Moderna position as of Q2 2021 after selling out during the quarter.
  • Weld Capital Management sold 5,963 Moderna shares in Q2 2021, an estimated $781K.
  • Weld Capital Management first reported a position in Moderna in Q1 2019 and held it in 2 quarters.
  • Weld Capital Management's Moderna position peaked at $781K in Q1 2021.
  • 904 funds tracked by Wall St. Rank held Moderna as of Q2 2021.

Based on Weld Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.